New Study on CBD and Autism Enrolling Families

Published November 11, 2019 in NYU

Many families have considered the use of cannabidiol, or CBD, for treatment of their own or their child’s autism symptoms.  So far, it has only been rigorously studied to determine efficacy of seizure reduction in people affected with genetic causes of epilepsy.  A new study at New York University is now enrolling families affected by both autism and high levels of irritability in a placebo-controlled study.  People will be enrolled for about 3 months and have access to CBD or a placebo.   

To learn more about the study or to see if you qualify, please email

Filed under: , , ,